Last Updated : Monday, March 9, 2020 10:01:46

USFDA Accepts BLA for Mylan and Biocon’s Proposed Biosimilar for Review

BENGALURU / HERTFORDSHIRE (PITTSBURGH) / MUMBAI / RAJKOT – In a regulatory update as submitted to the Indian Stock Exchanges, Bengaluru headquartered biotechnology company Biocon Ltd said of USFDA having accepted BLA (Biologics License Application) for a proposed biosimilar Bevacizumab, for review.


For LONG READ, please click / log on / visit :-
https://datelinegujarat.blogspot.com


In case, if a reader wishes to VERIFY the above narrated news-report please CLICK here.


Follow DATELINE GUJARAT On :-

FacebookGoogle+LinkedinTwitterYouTube, Blogspot, Telegram, Instagram 


SHARE THIS NEWS ON :-

Do NOT follow this link or you will be banned from the site!